With less than a month to go before we congregate for the World Vaccine Congress in Washington in April, we are pleased to share the organisations and individuals who have progressed to the final shortlist for the VIE Awards.
After successful rounds of submissions and voting we now present the shortlist. The names below have been contacted to fill in a submission form for review by the Scientific Advisory Board, which contributes to the final decision. This will be announced on the evening of the 4th April at the Awards Dinner.
Good luck to all shortlisted; we look forward to celebrating your achievements at the Congress and Dinner.
Best Clinical Trial Company
Benchmark Research
Cedar Health Research
CTI Clinical Research Centre
Flourish Research
PanAmerican Clinical Research
Rochester Clinical Research
Velocity/Meridian Clinical Research
Best Clinical Trial Network
Accelerated Enrollment Solutions (AES)
Accellacare
Alliance for Multispecialty Research (AMR)
CenExel
DM Clinical Research
Pratia
Tekton Research
Best Central/Speciality Laboratory
Charles River Labs
ICON Labs
Labcorp Drug Development
Nexelis, a Q² Solutions Company
PPD Clinical Research business of Thermo Fisher Scientific
Viroclinics-DDL, a Cerba Research Company
Best Contract Research Organsation
FHI Clinical
ICON
IQVIA
Nexelis, a Q² Solutions Company
Parexel
PPD Clinical Research business of Thermo Fisher Scientific
Syneos Health
Best production/process development
3M
Bharat Biotech
Luminex
MilliporeSigma
Moderna
VGXI
Best new vaccine technology/platform
BioNTech – mRNA platform
GSK’s RSV vaccine candidate
Janssen’s RSV vaccine candidate
Moderna – RNA
NOVAVAX – RECOMBINANT PROTEIN-BASED VACCINE WITH MATRIX-M™ ADJUVANT
Pfizer’s RSV vaccine candidate
Vaxcyte, Inc. –XpressCF ™ cell-free protein synthesis platform
Best Pharma
AstraZeneca
GlaxoSmithKline
Janssen
Merck
Moderna
Pfizer
Sanofi Pasteur
Best logistics, technology, and cold chain delivery
DHL
Marken
Sanaria
Siemens
UPS
Viroclinics-DDL, a Cerba Research Company
World Courier
Best academic/research team
Center for Vaccine Development and Global Health, University of Maryland on Malaria – Dr Miriam K. Laufer
City of Hope – COVID-19, Dr Don Diamond
Institute for RNA Innovation, University of Pennsylvania – Dr Drew Weissman & Dr Katie Kariko
La Jolla Institute’s work on COVID-19 T-cell responses – Dr Alessandro Sette & Dr Shane Crotty
Precision Vaccines Program, Division of Infectious Diseases, Boston Children’s Hospital, Professor, Harvard Medical School – Dr Ofer Levy
Stanford University, Dr Bali Pulendran’s lab for pioneering systems biological approaches to assess mechanisms and correlates of vaccine responses
Texas Children’s Hospital Center for Vaccine Development – Dr Peter Hotez & Dr Maria Elena Bottazzi
UW Medicine’s research in preventative breast cancer vaccine – Dr Nora Disis
